• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减少盐摄入量对盐摄入过多患者夜尿症的影响。

Effect of salt intake reduction on nocturia in patients with excessive salt intake.

机构信息

Department of Urology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

出版信息

Neurourol Urodyn. 2019 Mar;38(3):927-933. doi: 10.1002/nau.23929. Epub 2019 Feb 1.

DOI:10.1002/nau.23929
PMID:30706965
Abstract

AIMS

To assess the efficacy of salt reduction for improving nocturia in patients with high salt intake.

METHODS

Changes in lower urinary symptoms and frequency volume chart by salt intake (men: 8 g/day; women: ≥7 g/day) were analyzed in this prospective study. Patients were instructed to use a brochure for salt intake restriction via interview once every four weeks. The daily salt intake was estimated by using spot urine samples.

RESULTS

Two-hundred twenty-three (69.5%) patients were successful in reducing their daily salt intake (S group), whereas 98 (30.5%) patients failed to reduce their salt intake (F group). In the S group, nocturia improved from 2.3 ± 0.9 to 1.4 ± 1.0, and nocturnal polyuria index (NPi) improved from 30.2 ± 7.5 to 27.7 ± 7.3% (P < 0.001). In the Core Lower Urinary Tract Symptom Score (CLSS) of the S group, Q3 (urgency) improved from 1.0 ± 1.0 to 0.9 ± 1.0 (P = 0.001); Q1 (diurnal frequency) (P < 0.001), and Q2 (nocturia) also improved (P < 0.001). Moreover, the quality of life parameter improved significantly (P < 0.001). The patients in the F group did not have improvements in any symptom during the study period.

CONCLUSIONS

Patients with nocturia who also have high salt intake should be advised to reduce their salt intake, as a lifestyle modification. Our results support the importance of randomized clinical trials with larger populations and the appropriate inclusion/exclusion criteria to conclude the clinical usefulness of salt reduction in this patient cohort.

摘要

目的

评估减少盐摄入对改善高盐摄入患者夜尿症的疗效。

方法

本前瞻性研究分析了根据盐摄入量(男性:8g/天;女性:≥7g/天)改变下尿路症状和频率体积图表。通过访谈,每四周一次,患者被指导使用小册子限制盐摄入量。通过使用点尿样估计每日盐摄入量。

结果

223 名(69.5%)患者成功减少了他们的日常盐摄入量(S 组),而 98 名(30.5%)患者未能减少盐摄入量(F 组)。在 S 组中,夜尿症从 2.3±0.9 改善到 1.4±1.0,夜间多尿指数(NPi)从 30.2±7.5 改善到 27.7±7.3%(P<0.001)。在 S 组的核心下尿路症状评分(CLSS)中,Q3(急迫性)从 1.0±1.0 改善到 0.9±1.0(P=0.001);Q1(日间频率)(P<0.001)和 Q2(夜尿症)也有所改善(P<0.001)。此外,生活质量参数显著改善(P<0.001)。在研究期间,F 组的患者在任何症状方面都没有改善。

结论

患有夜尿症且摄入高盐的患者应被建议改变生活方式,减少盐摄入量。我们的结果支持在更大的人群中进行随机临床试验并采用适当的纳入/排除标准的重要性,以得出盐减少在该患者群体中的临床有用性的结论。

相似文献

1
Effect of salt intake reduction on nocturia in patients with excessive salt intake.减少盐摄入量对盐摄入过多患者夜尿症的影响。
Neurourol Urodyn. 2019 Mar;38(3):927-933. doi: 10.1002/nau.23929. Epub 2019 Feb 1.
2
Daily salt intake is an independent risk factor for pollakiuria and nocturia.每日盐摄入量是尿频和夜尿症的独立危险因素。
Int J Urol. 2017 May;24(5):384-389. doi: 10.1111/iju.13321. Epub 2017 Mar 14.
3
Daily salt intake is associated with leg edema and nocturnal urinary volume in elderly men.老年人的日常盐摄入量与腿部水肿和夜间尿量有关。
Neurourol Urodyn. 2020 Jun;39(5):1550-1556. doi: 10.1002/nau.24401. Epub 2020 May 27.
4
Efficacy of salt reduction for managing overactive bladder symptoms: a prospective study in patients with excessive daily salt intake.减少盐摄入对治疗膀胱过度活动症症状的疗效:一项针对每日盐摄入量过高患者的前瞻性研究。
Sci Rep. 2021 Feb 18;11(1):4046. doi: 10.1038/s41598-021-83725-9.
5
The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study.下尿路症状疑似良性前列腺增生患者夜尿症的评估以及夜尿症药物或安慰剂治疗后的疗效分析:一项随机安慰剂对照研究。
BMC Urol. 2018 Dec 13;18(1):115. doi: 10.1186/s12894-018-0426-4.
6
Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms.加压素联合治疗在接受 α 受体阻滞剂治疗下尿路症状的男性患者中难治性夜间尿频。
J Urol. 2013 Jul;190(1):180-6. doi: 10.1016/j.juro.2013.01.057. Epub 2013 Jan 25.
7
Nocturia and polyuria in men referred with lower urinary tract symptoms, assessed using a 7-day frequency-volume chart.采用7天频率-尿量图表评估的伴有下尿路症状的男性夜尿症和多尿症。
BJU Int. 1999 Jun;83(9):1017-22. doi: 10.1046/j.1464-410x.1999.00090.x.
8
Tamsulosin reduces nighttime urine production in benign prostatic hyperplasia patients with nocturnal polyuria: a prospective open-label long-term study using frequency-volume chart.坦索罗辛可减少夜间多尿型良性前列腺增生患者夜间尿量:一项使用频率-容积图的前瞻性开放标签长期研究。
Neurourol Urodyn. 2012 Jan;31(1):80-5. doi: 10.1002/nau.21224. Epub 2011 Oct 28.
9
Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study.α1受体阻滞剂治疗下尿路症状患者残余夜尿的抗胆碱能附加治疗:一项多中心、前瞻性、随机研究
World J Urol. 2015 May;33(5):659-67. doi: 10.1007/s00345-014-1399-x. Epub 2014 Sep 16.
10
Determinants of nocturia severity in men, derived from frequency-volume charts.从频率-尿量图表得出的男性夜尿症严重程度的决定因素。
Scand J Urol. 2015 Apr;49(2):185-8. doi: 10.3109/21681805.2014.973901. Epub 2014 Nov 3.

引用本文的文献

1
Inverse association between dietary flavonoid intake and nocturia in middle-aged and older adults from NHANES 2007-2010.2007 - 2010年美国国家健康和营养检查调查(NHANES)中,中老年成年人膳食类黄酮摄入量与夜尿症之间的负相关关系。
Sci Rep. 2025 Feb 5;15(1):4423. doi: 10.1038/s41598-025-88681-2.
2
Oxidative stress-induced NCC activation in the development of nocturnal polyuria in mice: Therapeutic potential of a sustained hydrogen-releasing silicon-based agent.氧化应激诱导的小鼠夜间多尿发展过程中的NCC激活:一种持续释氢的硅基制剂的治疗潜力
Biochem Biophys Rep. 2025 Jan 20;41:101923. doi: 10.1016/j.bbrep.2025.101923. eCollection 2025 Mar.
3
Decreased nitric oxide production is a novel therapeutic target for salt-induced nocturnal polyuria in aging.
一氧化氮生成减少是衰老过程中盐诱导的夜间多尿的一个新的治疗靶点。
Sci Rep. 2025 Jan 28;15(1):3589. doi: 10.1038/s41598-025-86526-6.
4
Analysis of Nocturia Determinants Using a Novel Portable Urine-Measuring Device.使用新型便携式尿液测量装置对夜尿症决定因素的分析。
Neurourol Urodyn. 2025 Apr;44(4):722-727. doi: 10.1002/nau.25667. Epub 2025 Jan 20.
5
The Influence of Dietary Habits on Male Lower Urinary Tract Symptoms: Differential Influence of Water Intake on Voiding Symptoms and Storage Symptoms.饮食习惯对男性下尿路症状的影响:水分摄入对排尿症状和储尿症状的不同影响。
World J Mens Health. 2025 Jul;43(3):647-660. doi: 10.5534/wjmh.230361. Epub 2024 Nov 20.
6
Disruption of circadian rhythm as a potential pathogenesis of nocturia.昼夜节律紊乱作为夜尿症的一种潜在发病机制。
Nat Rev Urol. 2025 May;22(5):276-293. doi: 10.1038/s41585-024-00961-0. Epub 2024 Nov 14.
7
Multicenter, open label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study.多中心、开放标签、随机对照优势试验以评估减少夜间排尿频率的有效性:TOP-STAR研究。
J Diabetes Investig. 2024 Dec;15(12):1809-1817. doi: 10.1111/jdi.14314. Epub 2024 Sep 18.
8
Application of the Sleep C.A.L.M. Tool for Assessing Nocturia in a Large Nationally Representative Cohort.睡眠C.A.L.M.工具在全国代表性大样本队列中评估夜尿症的应用
Int Neurourol J. 2024 Feb;28(Suppl 1):55-61. doi: 10.5213/inj.2346258.129. Epub 2024 Feb 29.
9
The Influence of Salt Sensitivity Phenotype on Sodium Excretion and Diuresis: A Chrononutrition Pilot Study.盐敏感性表型对钠排泄和利尿的影响:一项时间营养的初步研究。
Int J Clin Pract. 2022 Jan 31;2022:9608962. doi: 10.1155/2022/9608962. eCollection 2022.
10
Relationship between Urinary Calcium Excretion and Lower Urinary Tract Symptoms.尿钙排泄与下尿路症状之间的关系
Metabolites. 2022 Mar 5;12(3):229. doi: 10.3390/metabo12030229.